Member Exclusive

Cell therapy weekly: Acting FDA Commissioner named as Ned Sharpless

This week: Fujifilm to acquire Biogen manufacturing site and new phase II trial will pit stem cells against MS

Go to the profile of RegMedNet
Mar 14, 2019

Please sign in or register for FREE

No comments yet.